This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
unigram | frequency |
---|---|
patients | 3026 |
strains | 1710 |
results | 1647 |
isolates | 1647 |
study | 1500 |
resistance | 1407 |
clinical | 1312 |
methods | 1204 |
infection | 1159 |
pcr | 1051 |
infections | 1029 |
using | 919 |
positive | 918 |
mg | 896 |
respiratory | 886 |
treatment | 879 |
resistant | 866 |
one | 840 |
samples | 819 |
two | 816 |
mic | 764 |
cases | 730 |
hospital | 728 |
among | 724 |
used | 712 |
group | 712 |
data | 705 |
analysis | 700 |
antibiotic | 636 |
also | 632 |
disease | 618 |
different | 616 |
found | 610 |
days | 593 |
associated | 591 |
virus | 587 |
objectives | 586 |
gene | 580 |
may | 578 |
aureus | 577 |
test | 574 |
detection | 570 |
time | 568 |
use | 562 |
respectively | 558 |
high | 547 |
years | 546 |
negative | 539 |
genes | 532 |
mrsa | 528 |
performed | 526 |
bacterial | 515 |
studies | 514 |
covid | 512 |
detected | 512 |
isolated | 504 |
susceptibility | 504 |
patient | 499 |
activity | 499 |
non | 497 |
therapy | 483 |
ml | 476 |
conclusion | 473 |
tested | 469 |
blood | 466 |
antibiotics | 464 |
conclusions | 454 |
viral | 451 |
compared | 450 |
showed | 447 |
antimicrobial | 443 |
identified | 442 |
three | 438 |
pneumoniae | 431 |
species | 429 |
influenza | 427 |
type | 424 |
method | 424 |
risk | 424 |
bacteria | 419 |
pathogens | 412 |
control | 409 |
human | 406 |
total | 404 |
sars | 399 |
age | 397 |
determined | 395 |
first | 395 |
viruses | 387 |
cov | 385 |
well | 375 |
based | 373 |
i | 370 |
significant | 369 |
included | 367 |
strain | 366 |
including | 364 |
pneumonia | 360 |
new | 357 |
specific | 351 |
care | 351 |
common | 350 |
however | 349 |
testing | 344 |
diagnosis | 344 |
observed | 343 |
prevalence | 342 |
gram | 341 |
hospitals | 341 |
period | 340 |
laboratory | 337 |
day | 337 |
groups | 336 |
children | 334 |
number | 333 |
assay | 331 |
obtained | 327 |
due | 327 |
presence | 326 |
culture | 326 |
reported | 326 |
rate | 323 |
specimens | 322 |
acute | 321 |
collected | 317 |
vs | 317 |
coli | 316 |
severe | 314 |
higher | 309 |
drug | 308 |
related | 308 |
dna | 306 |
case | 303 |
identification | 301 |
according | 300 |
mean | 297 |
mortality | 296 |
rates | 293 |
tests | 285 |
molecular | 285 |
low | 284 |
susceptible | 283 |
sensitivity | 279 |
diseases | 279 |
agents | 278 |
table | 278 |
factors | 274 |
diagnostic | 274 |
present | 274 |
vitro | 273 |
increased | 272 |
tract | 272 |
infectious | 270 |
concentrations | 270 |
spp | 267 |
rapid | 265 |
community | 264 |
objective | 263 |
within | 261 |
population | 260 |
system | 258 |
treated | 258 |
significantly | 257 |
acquired | 257 |
four | 257 |
vancomycin | 257 |
important | 254 |
year | 254 |
staphylococcus | 253 |
per | 251 |
infected | 250 |
similar | 248 |
health | 246 |
effect | 245 |
symptoms | 245 |
serum | 245 |
range | 245 |
level | 243 |
beta | 243 |
incidence | 240 |
mics | 240 |
surveillance | 238 |
medical | 235 |
model | 228 |
confirmed | 228 |
ci | 225 |
sample | 225 |
without | 223 |
single | 221 |
sequence | 221 |
fever | 220 |
potential | 217 |
rt | 216 |
transmission | 214 |
hours | 214 |
shown | 213 |
novel | 212 |
several | 211 |
although | 211 |
lower | 211 |
levels | 209 |
concentration | 209 |
increase | 209 |
coronavirus | 205 |
agar | 205 |
analysed | 204 |
values | 203 |
will | 201 |
overall | 201 |
caused | 201 |
pathogen | 200 |
tissue | 200 |
differences | 200 |
studied | 200 |
available | 200 |
iv | 199 |
subjects | 198 |
difficile | 198 |
cause | 197 |
tigecycline | 197 |
spectrum | 197 |
considered | 197 |
ciprofloxacin | 196 |
dose | 196 |
aeruginosa | 195 |
penicillin | 195 |
determine | 195 |
five | 193 |
following | 191 |
linezolid | 190 |
standard | 189 |
sequencing | 189 |
received | 188 |
six | 186 |
cultures | 186 |
acid | 185 |
pfge | 184 |
esbl | 184 |
major | 184 |
lg | 184 |
aim | 183 |
cells | 180 |
icu | 180 |
evaluated | 179 |
rna | 179 |
response | 178 |
months | 178 |
primary | 176 |
role | 176 |
efficacy | 176 |
hospitalized | 175 |
like | 174 |
effective | 173 |
protein | 173 |
frequently | 173 |
possible | 172 |
less | 171 |
pylori | 171 |
skin | 169 |
adults | 169 |
described | 169 |
types | 168 |
outbreak | 168 |
methicillin | 168 |
countries | 168 |
many | 168 |
imipenem | 167 |
ii | 167 |
research | 167 |
phenotype | 166 |
evaluate | 166 |
cell | 165 |
erythromycin | 165 |
real | 164 |
characteristics | 163 |
since | 163 |
oral | 163 |
least | 162 |
co | 162 |
admission | 162 |
guidelines | 162 |
tetracycline | 160 |
management | 159 |
anti | 158 |
median | 157 |
isolate | 156 |
isolation | 155 |
followed | 155 |
duration | 155 |
distribution | 154 |
comparison | 154 |
known | 154 |
developed | 153 |
cord | 153 |
production | 153 |
early | 153 |
nosocomial | 153 |
information | 153 |
toxin | 153 |
antibodies | 152 |
presented | 152 |
reduced | 152 |
selected | 152 |
nccls | 152 |
producing | 151 |
cost | 150 |
spread | 150 |
findings | 150 |
chronic | 149 |
especially | 149 |
drugs | 149 |
region | 148 |
value | 148 |
development | 148 |
levofloxacin | 147 |
csf | 147 |
organisms | 147 |
microbiology | 147 |
european | 146 |
invasive | 145 |
large | 144 |
active | 144 |
broth | 144 |
cfu | 143 |
typing | 143 |
authors | 143 |
recent | 142 |
addition | 142 |
women | 142 |
assays | 141 |
order | 141 |
investigated | 141 |
reference | 140 |
carried | 140 |
moxifloxacin | 139 |
increasing | 139 |
frequency | 139 |
second | 139 |
grn | 139 |
criteria | 138 |
patterns | 138 |
epidemic | 138 |
combination | 137 |
whereas | 136 |
failure | 136 |
public | 135 |
microbiological | 135 |
difference | 134 |
streptococcus | 134 |
area | 133 |
quality | 133 |
cohort | 133 |
igg | 132 |
controls | 132 |
genetic | 132 |
evaluation | 131 |
therefore | 131 |
multiple | 131 |
defined | 131 |
demonstrated | 131 |
key | 130 |
result | 130 |
individuals | 128 |
exposure | 128 |
st | 128 |
impact | 127 |
growth | 127 |
cap | 127 |
previous | 127 |
often | 127 |
frequent | 127 |
normal | 127 |
clindamycin | 127 |
suggest | 126 |
broad | 126 |
outcome | 126 |
sequences | 124 |
taken | 124 |
adult | 124 |
europe | 123 |
collection | 123 |
trials | 123 |
association | 123 |
admitted | 123 |
assessed | 123 |
general | 123 |
agent | 122 |
report | 122 |
illness | 122 |
previously | 122 |
virulence | 121 |
commonly | 121 |
screening | 121 |
specificity | 121 |
therapeutic | 121 |
conducted | 121 |
detect | 120 |
might | 120 |
versus | 119 |
changes | 119 |
revealed | 119 |
old | 119 |
factor | 119 |
meningitis | 119 |
university | 119 |
even | 118 |
lactamase | 118 |
recently | 118 |
diarrhoea | 118 |
erm | 117 |
decreased | 117 |
mutations | 117 |
phase | 116 |
administration | 116 |
candida | 116 |
conditions | 116 |
various | 116 |
water | 116 |
given | 116 |
highly | 116 |
proportion | 115 |
examined | 115 |
recovered | 115 |
enterobacteriaceae | 113 |
review | 112 |
pandemic | 112 |
regions | 112 |
assess | 111 |
post | 111 |
prospective | 111 |
need | 111 |
routine | 111 |
still | 111 |
humans | 111 |
main | 110 |
survival | 110 |
intensive | 110 |
staphylococci | 110 |
class | 110 |
primers | 110 |
mice | 110 |
despite | 110 |
likely | 110 |
expression | 110 |
mainly | 110 |
majority | 110 |
weeks | 109 |
reaction | 109 |
identify | 108 |
either | 108 |
us | 108 |
swabs | 108 |
plasma | 108 |
analyses | 108 |
reduction | 108 |
laboratories | 108 |
outcomes | 107 |
unit | 107 |
elisa | 107 |
fluid | 107 |
seven | 107 |
amplification | 107 |
anaerobic | 107 |
usa | 106 |
asymptomatic | 106 |
urine | 106 |
evidence | 106 |
pattern | 106 |
healthy | 105 |
clinically | 105 |
severity | 105 |
ampicillin | 105 |
plasmid | 105 |
hospitalization | 105 |
faecium | 105 |
syndrome | 105 |
log | 105 |
igm | 105 |
auc | 104 |
individual | 104 |
ratio | 104 |
macrolide | 104 |
daily | 104 |
date | 104 |
epidemiology | 103 |
multi | 103 |
rsv | 103 |
enterococcus | 103 |
background | 103 |
occurred | 103 |
id | 103 |
limited | 102 |
sensitive | 102 |
salmonella | 102 |
dilution | 102 |
correlation | 102 |
animals | 102 |
required | 102 |
pulmonary | 101 |
healthcare | 101 |
clone | 101 |
approach | 101 |
hcws | 101 |
profile | 101 |
responsible | 101 |
pk | 101 |
outbreaks | 100 |
stay | 100 |
world | 100 |
central | 100 |
plates | 99 |
last | 99 |
involved | 99 |
prevention | 99 |
suspected | 99 |
small | 98 |
part | 97 |
sp | 97 |
good | 97 |
statistical | 96 |
diagnosed | 96 |
china | 95 |
work | 95 |
systems | 94 |
epidemiological | 94 |
pts | 94 |
hmpv | 93 |
mechanisms | 93 |
appropriate | 93 |
ceftriaxone | 93 |
van | 93 |
centres | 93 |
done | 93 |
antigen | 93 |
min | 93 |
urinary | 93 |
tet | 92 |
death | 92 |
surgery | 92 |
atcc | 92 |
better | 92 |
antimicrobials | 92 |
material | 92 |
field | 92 |
kg | 92 |
provide | 92 |
gentamicin | 91 |
sites | 91 |
episodes | 91 |
emerging | 91 |
trial | 91 |
media | 91 |
end | 91 |
length | 91 |
current | 91 |
consumption | 90 |
vaccine | 90 |
diffusion | 90 |
genome | 90 |
nine | 89 |
follow | 89 |
moderate | 89 |
staff | 89 |
bacteraemia | 89 |
contamination | 89 |
iii | 89 |
liver | 89 |
long | 89 |
site | 89 |
intravenous | 88 |
course | 88 |
initial | 88 |
measures | 88 |
multiplex | 88 |
disk | 88 |
areas | 88 |
cefepime | 88 |
ctx | 88 |
local | 87 |
extraction | 87 |
automated | 87 |
hospitalised | 87 |
hand | 87 |
expected | 87 |
animal | 87 |
made | 87 |
score | 87 |
uk | 87 |
ceftazidime | 87 |
calculated | 87 |
ct | 87 |
mssa | 86 |
chlamydia | 86 |
secondary | 86 |
examination | 86 |
alone | 86 |
whether | 86 |
profiles | 86 |
wuhan | 86 |
prior | 85 |
antibody | 85 |
france | 85 |
faecalis | 85 |
serious | 85 |
worldwide | 85 |
ca | 85 |
escherichia | 85 |
cephalosporins | 85 |
national | 85 |
onset | 84 |
emergence | 84 |
microdilution | 84 |
infect | 84 |
mild | 84 |
colonisation | 84 |
rapidly | 84 |
recommended | 84 |
amoxicillin | 84 |
male | 83 |
rrna | 83 |
setting | 83 |
third | 83 |
surgical | 83 |
journal | 83 |
streptococci | 83 |
cough | 83 |
applied | 83 |
genotype | 83 |
baumannii | 82 |
microbiol | 82 |
nasal | 82 |
sputum | 82 |
times | 82 |
lrti | 82 |
direct | 82 |
pseudomonas | 81 |
clin | 81 |
temperature | 81 |
klebsiella | 81 |
corresponding | 81 |
greater | 81 |
point | 81 |
mcg | 81 |
effects | 81 |
cns | 81 |
critical | 81 |
inflammatory | 81 |
highest | 81 |
features | 81 |
bactericidal | 81 |
enzyme | 80 |
ab | 80 |
mutation | 80 |
knowledge | 80 |
form | 80 |
eight | 80 |
adverse | 80 |
cmi | 80 |
serotype | 80 |
rs | 80 |
rhinovirus | 79 |
target | 79 |
administered | 79 |
environmental | 79 |
influenzae | 79 |
older | 79 |
regression | 79 |
introduction | 79 |
seen | 79 |
doi | 79 |
paediatric | 79 |
cross | 79 |
investigate | 79 |
fold | 78 |
efflux | 78 |
teicoplanin | 78 |
ability | 78 |
antibacterial | 78 |
centre | 78 |
show | 78 |
hiv | 78 |
containing | 78 |
renal | 78 |
enterococci | 78 |
bp | 78 |
parameters | 78 |
importance | 78 |
pvl | 78 |
spain | 77 |
currently | 77 |
particularly | 77 |
structure | 77 |
mechanism | 77 |
except | 77 |
occurrence | 77 |
acinetobacter | 77 |
retrospective | 77 |
medium | 77 |
load | 77 |
antifungal | 77 |
remains | 77 |
particular | 77 |
immune | 77 |
prevalent | 77 |
catheter | 77 |
decrease | 76 |
history | 76 |
source | 76 |
another | 76 |
support | 76 |
sepsis | 76 |
origin | 76 |
hts | 76 |
sd | 76 |
specimen | 76 |
il | 76 |
furthermore | 76 |
pd | 76 |
practice | 75 |
serotypes | 75 |
measured | 75 |
half | 75 |
counts | 75 |
doses | 75 |
contact | 75 |
title | 75 |
average | 75 |
clostridium | 74 |
lung | 74 |
performance | 74 |
ia | 74 |
investigation | 74 |
gastric | 73 |
become | 73 |
intervention | 73 |
coagulase | 73 |
department | 73 |
endemic | 73 |
established | 73 |
proteins | 73 |
germany | 73 |
pre | 73 |
relevant | 73 |
enrolled | 72 |
uid | 72 |
sha | 72 |
models | 72 |
atypical | 72 |
published | 72 |
treatments | 72 |
wide | 72 |
nasopharyngeal | 72 |
encephalitis | 72 |
experiments | 72 |
doc | 72 |
receiving | 72 |
products | 71 |
incubation | 71 |
january | 71 |
conventional | 71 |
life | 71 |
electrophoresis | 71 |
controlled | 71 |
swab | 70 |
antiviral | 70 |
bone | 70 |
concern | 70 |
month | 70 |
causing | 70 |
plus | 70 |
wards | 70 |
accuracy | 70 |
database | 70 |
populations | 70 |
combined | 70 |
prescribed | 70 |
phage | 70 |
cip | 69 |
responses | 69 |
fluoroquinolones | 69 |
underlying | 69 |
improved | 69 |
organism | 69 |
cancer | 69 |
needed | 69 |
safety | 69 |
designed | 69 |
compare | 69 |
clones | 69 |
reduce | 69 |
free | 69 |
syncytial | 68 |
kill | 68 |
randomized | 68 |
seasonal | 68 |
complicated | 68 |
suggesting | 68 |
none | 68 |
pooling | 68 |
statistically | 68 |
extracted | 68 |
costs | 68 |
reports | 68 |
percentage | 68 |
exposed | 68 |
improve | 67 |
fungal | 67 |
people | 67 |
environment | 67 |
italy | 67 |
young | 67 |
influence | 67 |
protocol | 67 |
pneumococcal | 67 |
gel | 67 |
term | 67 |
epidermidis | 67 |
sampling | 67 |
additional | 67 |
stool | 67 |
aged | 67 |
ie | 67 |
mef | 67 |
approximately | 67 |
relationship | 67 |
food | 67 |
metronidazole | 67 |
units | 67 |
adenovirus | 66 |
regarding | 66 |
albicans | 66 |
useful | 66 |
problem | 66 |
predictive | 66 |
north | 66 |
sources | 66 |
vaccination | 66 |
complications | 66 |
encoding | 66 |
biofilm | 66 |
double | 66 |
medicine | 66 |
carbapenems | 66 |
size | 65 |
short | 65 |
brain | 65 |
host | 65 |
moreover | 65 |
events | 65 |
ill | 65 |
contrast | 65 |
global | 65 |
lack | 65 |
generation | 65 |
upper | 65 |
heart | 65 |
th | 65 |
cmv | 64 |
consistent | 64 |
clonal | 64 |
now | 64 |
strategies | 64 |
technique | 64 |
provided | 64 |
necessary | 64 |
determination | 64 |
cure | 64 |
program | 64 |
eradication | 64 |
relatively | 64 |
describe | 64 |
develop | 64 |
extended | 64 |
survey | 63 |
monitoring | 63 |
genotypes | 63 |
characterised | 63 |
vivo | 63 |
cm | 63 |
hpv | 63 |
seems | 63 |
procedure | 63 |
crp | 63 |
piperacillin | 63 |
rare | 63 |
shows | 63 |
colistin | 63 |
lzd | 63 |
basis | 63 |
usually | 63 |
anthrax | 63 |
mm | 62 |
probably | 62 |
lactamases | 62 |
empiric | 62 |
cultured | 62 |
process | 62 |
change | 62 |
signs | 62 |
future | 62 |
recorded | 62 |
potent | 62 |
poor | 62 |
contained | 61 |
helicobacter | 61 |
amikacin | 61 |
meropenem | 61 |
together | 61 |
diabetes | 61 |
observational | 61 |
resulted | 61 |
predominant | 61 |
unique | 61 |
clarithromycin | 61 |
rv | 61 |
alternative | 60 |
chain | 60 |
difficult | 60 |
phenotypic | 60 |
interest | 60 |
techniques | 60 |
persons | 60 |
indicated | 60 |
finally | 60 |
series | 60 |
workers | 60 |
affected | 60 |
tlv | 60 |
kit | 60 |
causative | 60 |
sex | 60 |
pathogenic | 60 |
amplified | 59 |
elevated | 59 |
absence | 59 |
remained | 59 |
screened | 59 |
carriage | 59 |
presentation | 59 |
morbidity | 59 |
ranging | 59 |
macrolides | 59 |
ten | 59 |
unknown | 59 |
selection | 59 |
sera | 58 |
binding | 58 |
penetration | 58 |
nvhap | 58 |
restriction | 58 |
variation | 58 |
inhibitory | 58 |
tig | 58 |
continuous | 58 |
week | 58 |
endocarditis | 58 |
faecal | 58 |
choice | 58 |
experimental | 58 |
mutants | 58 |
identical | 58 |
intestinal | 58 |
characterized | 58 |
twenty | 58 |
genomic | 57 |
baseline | 57 |
best | 57 |
see | 57 |
bal | 57 |
ranged | 57 |
experience | 57 |
transfer | 57 |
comparable | 57 |
full | 57 |
mdr | 57 |
strategy | 57 |
prolonged | 56 |
indicate | 56 |
plasmids | 56 |
ward | 56 |
oxa | 56 |
count | 56 |
help | 56 |
distinct | 56 |
recommendations | 56 |
burden | 56 |
april | 56 |
set | 56 |
consecutive | 56 |
complex | 56 |
produced | 56 |
variable | 56 |
around | 55 |
internal | 55 |
estimated | 55 |
hhv | 55 |
prophylaxis | 55 |
family | 55 |
line | 55 |
reviewed | 55 |
colonization | 55 |
uti | 55 |
surface | 55 |
azithromycin | 55 |
lactam | 55 |
carrying | 55 |
selective | 55 |
caga | 55 |
eu | 55 |
quinolone | 54 |
country | 54 |
expressed | 54 |
status | 54 |
treat | 54 |
microorganisms | 54 |
mixed | 54 |
abscess | 54 |
copies | 54 |
microbial | 54 |
aerobic | 54 |
belonged | 54 |
systematic | 54 |
noted | 54 |
reliable | 54 |
bacteroides | 54 |
suggests | 54 |
prescribing | 54 |
elderly | 54 |
transplant | 53 |
men | 53 |
aetiology | 53 |
emergency | 53 |
ae | 53 |
correlated | 53 |
lead | 53 |
pooled | 53 |
include | 53 |
tertiary | 53 |
materials | 53 |
nucleic | 53 |
inhibition | 53 |
infusion | 53 |
tazobactam | 53 |
far | 53 |
inhibitors | 53 |
directly | 53 |
dosing | 53 |
design | 53 |
quantitative | 53 |
aimed | 53 |
much | 53 |
evolution | 53 |
confirm | 53 |
cefotaxime | 53 |
polymerase | 53 |
improvement | 53 |
characterisation | 52 |
procedures | 52 |
phylogenetic | 52 |
enzymes | 52 |
others | 52 |
gastrointestinal | 52 |
challenge | 52 |
panel | 52 |
complete | 52 |
mps | 52 |
almost | 52 |
march | 52 |
air | 52 |
members | 52 |
fact | 52 |
comparative | 52 |
surfaces | 52 |
excluded | 52 |
located | 52 |
literature | 52 |
exhibited | 52 |
international | 52 |
causes | 52 |
index | 52 |
whole | 52 |
soft | 52 |
determinants | 52 |
quinolones | 51 |
inhibited | 51 |
effectiveness | 51 |
pregnant | 51 |
remaining | 51 |
cdi | 51 |
able | 51 |
ddd | 51 |
comprehensive | 51 |
kb | 51 |
presenting | 51 |
vitek | 51 |
multidrug | 51 |
shock | 51 |
microscopy | 51 |
great | 51 |
mostly | 51 |
flora | 51 |
assessment | 50 |
variables | 50 |
reverse | 50 |
vre | 50 |
pressure | 50 |
gm | 50 |
suggested | 50 |
final | 50 |
wound | 50 |
abdominal | 50 |
physicians | 50 |
tlr | 50 |
pools | 50 |
step | 50 |
lowest | 50 |
aspergillosis | 50 |
female | 50 |
died | 50 |
significance | 50 |
success | 50 |
terms | 50 |
pharmacokinetic | 49 |
western | 49 |
serological | 49 |
regardless | 49 |
variants | 49 |
curve | 49 |
later | 49 |
varied | 49 |
hp | 49 |
mediated | 49 |
prevent | 49 |
classes | 49 |
represent | 49 |
gr | 49 |
reactive | 49 |
symptomatic | 49 |
properties | 49 |
every | 48 |
validation | 48 |
vana | 48 |
logistic | 48 |
tgc | 48 |
incubated | 48 |
infants | 48 |
daptomycin | 48 |
induced | 48 |
situation | 48 |
america | 48 |
widely | 48 |
documented | 48 |
critically | 48 |
leading | 48 |
tuberculosis | 48 |
october | 48 |
appears | 48 |
recombinant | 48 |
dependent | 48 |
oxacillin | 48 |
supplementary | 48 |
phenotypes | 47 |
netherlands | 47 |
way | 47 |
47 | |
stage | 47 |
volume | 47 |
cp | 47 |
probe | 47 |
cdad | 47 |
validated | 47 |
generally | 47 |
united | 47 |
systemic | 47 |
cd | 47 |
cc | 47 |
function | 47 |
late | 47 |
pain | 47 |
hygiene | 47 |
potentially | 47 |
led | 47 |
inhibitor | 47 |
glycopeptides | 47 |
volunteers | 47 |
yet | 46 |
mlsb | 46 |
mxf | 46 |
discharge | 46 |
diversity | 46 |
microflora | 46 |
commercial | 46 |
combinations | 46 |
chloramphenicol | 46 |
reporting | 46 |
across | 46 |
relation | 46 |
season | 46 |
account | 46 |
gastroenteritis | 46 |
recognized | 46 |
inclusion | 46 |
pulsed | 46 |
streptococcal | 46 |
mutant | 46 |
saliva | 46 |
sequenced | 46 |
gbs | 45 |
via | 45 |
state | 45 |
interpreted | 45 |
independent | 45 |
biopsy | 45 |
benefit | 45 |
tissues | 45 |
interval | 45 |
filmarray | 45 |
participating | 45 |
immunocompromised | 45 |
glycopeptide | 45 |
approved | 45 |
fragilis | 45 |
gisa | 45 |
hybridisation | 45 |
probes | 45 |
means | 44 |
allowed | 44 |
telithromycin | 44 |
enterovirus | 44 |
ribotype | 44 |
blaoxa | 44 |
tr | 44 |
estimate | 44 |
pathogenesis | 44 |
inoculum | 44 |
younger | 44 |
flu | 44 |
december | 44 |
degree | 44 |
protection | 44 |
randomised | 44 |
fragment | 44 |
subsequent | 44 |
anaerobes | 44 |
diagnostics | 44 |
fq | 44 |
ulcer | 44 |
ampc | 44 |
achieved | 44 |
participants | 44 |
throat | 44 |
cq | 44 |
nucleotide | 43 |
inflammation | 43 |
esbls | 43 |
acquisition | 43 |
periods | 43 |
loss | 43 |
accurate | 43 |
colonies | 43 |
primer | 43 |
compounds | 43 |
yielded | 43 |
derived | 43 |
shv | 43 |
trends | 43 |
proven | 43 |
cluster | 43 |
cons | 43 |
outpatient | 43 |
finding | 43 |
tool | 43 |
hundred | 43 |
po | 43 |
preliminary | 43 |
intra | 43 |
greece | 43 |
corticosteroid | 42 |
tn | 42 |
interventions | 42 |
already | 42 |
turkey | 42 |
repeated | 42 |
growing | 42 |
ec | 42 |
sub | 42 |
prescription | 42 |
rotavirus | 42 |
lesions | 42 |
gas | 42 |
relative | 42 |
body | 42 |
meta | 42 |
interpretation | 42 |
software | 42 |
settings | 42 |
bloodstream | 42 |
contaminated | 41 |
implementation | 41 |
na | 41 |
mupirocin | 41 |
optimal | 41 |
states | 41 |
ery | 41 |
application | 41 |
must | 41 |
divided | 41 |
hinton | 41 |
csssi | 41 |
minocycline | 41 |
borne | 41 |
trend | 41 |
close | 41 |
numbers | 41 |
ms | 41 |
questionnaire | 41 |
fear | 41 |
economic | 41 |
breakpoints | 41 |
bed | 41 |
belonging | 41 |
sa | 41 |
formation | 40 |
amino | 40 |
longer | 40 |
south | 40 |
imi | 40 |
approaches | 40 |
subsequently | 40 |
dalfopristin | 40 |
comparing | 40 |
producers | 40 |
respect | 40 |
throughout | 40 |
immunoassay | 40 |
variability | 40 |
ermb | 40 |
recovery | 40 |
classified | 40 |
trimethoprim | 40 |
malaria | 40 |
always | 40 |
hospitalisation | 40 |
eia | 40 |
recipients | 40 |
represents | 40 |
understanding | 40 |
manifestations | 40 |
hi | 40 |
activities | 40 |
ari | 39 |
hour | 39 |
clinic | 39 |
natural | 39 |
emm | 39 |
demographic | 39 |
teaching | 39 |
clsi | 39 |
wild | 39 |
homeless | 39 |
grade | 39 |
biochemical | 39 |
maximum | 39 |
pi | 39 |
added | 39 |
false | 39 |
vap | 39 |
showing | 39 |
dap | 39 |
occur | 39 |
positivity | 38 |
aspergillus | 38 |
purpose | 38 |
place | 38 |
cvc | 38 |
febrile | 38 |
developing | 38 |
open | 38 |
simple | 38 |
quinupristin | 38 |
semi | 38 |
fm | 38 |
progression | 38 |
additionally | 38 |
prospectively | 38 |
strong | 38 |
minutes | 38 |
glabrata | 38 |
pregnancy | 38 |
home | 38 |
hydroxychloroquine | 38 |
perform | 38 |
content | 38 |
aminoglycosides | 38 |
hcw | 38 |
toxins | 38 |
allows | 37 |
increases | 37 |
contribute | 37 |
regimens | 37 |
confidence | 37 |
cmax | 37 |
carriers | 37 |
cl | 37 |
frequencies | 37 |
hepatitis | 37 |
rather | 37 |
appeared | 37 |
matched | 37 |
biological | 37 |
along | 37 |
minimum | 37 |
route | 37 |
hong | 37 |
nvp | 37 |
recurrent | 37 |
essential | 37 |
methodology | 37 |
outpatients | 37 |
receive | 37 |
sent | 37 |
caz | 37 |
living | 37 |
resulting | 37 |
play | 37 |
clusters | 37 |
thirty | 37 |
focus | 37 |
mueller | 37 |
syphilis | 37 |
shorter | 37 |
adequate | 37 |
stx | 36 |
ratios | 36 |
serology | 36 |
started | 36 |
implications | 36 |
standards | 36 |
intermediate | 36 |
includes | 36 |
gastritis | 36 |
campylobacter | 36 |
fluconazole | 36 |
bacilli | 36 |
antigens | 36 |
requiring | 36 |
subtypes | 36 |
numerous | 36 |
iqr | 36 |
subject | 36 |
equal | 36 |
possibility | 36 |
proved | 36 |
api | 36 |
clearly | 36 |
provides | 36 |
predictors | 36 |
efficient | 36 |
bsi | 36 |
gave | 36 |
clinicians | 36 |
adjusted | 36 |
points | 36 |
serogroup | 36 |
etest | 36 |
little | 36 |
clearance | 35 |
efficiency | 35 |
chest | 35 |
gyra | 35 |
variety | 35 |
condition | 35 |
failed | 35 |
disinfection | 35 |
dissemination | 35 |
certain | 35 |
potency | 35 |
ph | 35 |
modified | 35 |
pharmacokinetics | 35 |
towards | 35 |
east | 35 |
southern | 35 |
fluoroquinolone | 35 |
brucella | 35 |
successful | 35 |
agglutination | 35 |
increasingly | 35 |
special | 35 |
vp | 35 |
haemophilus | 35 |
staphylococcal | 35 |
kong | 35 |
rflp | 35 |
clavulanic | 35 |
parc | 35 |
valve | 35 |
aztreonam | 35 |
wounds | 35 |
limit | 35 |
kpc | 35 |
bias | 35 |
investigations | 35 |
linked | 34 |
limitations | 34 |
beginning | 34 |
vaginal | 34 |
hajj | 34 |
aes | 34 |
pip | 34 |
elements | 34 |
submitted | 34 |
titre | 34 |
lc | 34 |
dengue | 34 |
prepared | 34 |
typhimurium | 34 |
encoded | 34 |
travel | 34 |
corticosteroids | 34 |
mfx | 34 |
ones | 34 |
ncov | 34 |
meca | 34 |
analytical | 34 |
usage | 34 |
piv | 34 |
chinese | 34 |
product | 34 |
multivariate | 34 |
cefuroxime | 34 |
stec | 34 |
sulbactam | 34 |
ac | 34 |
treating | 34 |
harbouring | 34 |
interestingly | 34 |
excellent | 34 |
agr | 34 |
prognosis | 34 |
option | 34 |
vanb | 33 |
diabetic | 33 |
strongly | 33 |
indicating | 33 |
density | 33 |
pen | 33 |
algorithm | 33 |
sxt | 33 |
allow | 33 |
variant | 33 |
taking | 33 |
genotypic | 33 |
search | 33 |
cut | 33 |
center | 33 |
symptom | 33 |
panels | 33 |
represented | 33 |
rep | 33 |
comparator | 33 |
transferred | 33 |
latter | 33 |
metapneumovirus | 33 |
pyogenes | 33 |
closely | 33 |
cerebrospinal | 33 |
fatal | 33 |
training | 33 |
produce | 33 |
distributed | 33 |
discussion | 33 |
rifampicin | 33 |
earlier | 33 |
remain | 33 |
carbapenem | 33 |
pt | 33 |
version | 33 |
pneumococci | 33 |
concomitant | 33 |
february | 32 |
scan | 32 |
randomly | 32 |
probability | 32 |
ertapenem | 32 |
italian | 32 |
social | 32 |
enterococcal | 32 |
education | 32 |
detecting | 32 |
element | 32 |
issues | 32 |
newly | 32 |
departments | 32 |
tube | 32 |
became | 32 |
pilgrims | 32 |
regimen | 32 |
past | 32 |
flow | 32 |
respective | 32 |
organ | 32 |
demonstrate | 32 |
room | 32 |
action | 32 |
compliance | 32 |
cardiac | 32 |
scale | 32 |
extent | 32 |
resources | 32 |
inoculated | 32 |
needs | 32 |
pneumonias | 32 |
considering | 32 |
side | 32 |
genotyping | 32 |
ulcers | 32 |
cent | 32 |
next | 32 |
fr | 32 |
indicates | 32 |
reactions | 32 |
physical | 32 |
mass | 32 |
june | 32 |
probable | 32 |
legionella | 32 |
viable | 32 |
harboured | 32 |
differ | 31 |
problems | 31 |
transcription | 31 |
gender | 31 |
travellers | 31 |
bacillus | 31 |
proposed | 31 |
coverage | 31 |
targeted | 31 |
qc | 31 |
lin | 31 |
examine | 31 |
find | 31 |
records | 31 |
analyse | 31 |
release | 31 |
curves | 31 |
consent | 31 |
accounted | 31 |
infective | 31 |
suitable | 31 |
initially | 31 |
technology | 31 |
sheep | 31 |
substantial | 31 |
tem | 31 |
mlst | 31 |
meningoencephalitis | 31 |
peritonitis | 31 |
generated | 31 |
affect | 31 |
plate | 31 |
possibly | 31 |
monocytogenes | 31 |
supported | 31 |
reducing | 31 |
lev | 31 |
lactams | 31 |
context | 31 |
killing | 31 |
residents | 31 |
lineage | 31 |
categories | 31 |
informed | 31 |
deletion | 31 |
multicentre | 31 |
weight | 31 |
protocols | 31 |
parainfluenza | 31 |
registered | 31 |
appear | 31 |
belgium | 30 |
nan | 30 |
dosage | 30 |
nature | 30 |
occurs | 30 |
network | 30 |
abscesses | 30 |
ns | 30 |
working | 30 |
occurring | 30 |
staining | 30 |
vor | 30 |
serial | 30 |
monotherapy | 30 |
bd | 30 |
successfully | 30 |
tid | 30 |
agalactiae | 30 |
peak | 30 |
aminoglycoside | 30 |
indication | 30 |
considerable | 30 |
options | 30 |
immunity | 30 |
definition | 30 |
easy | 30 |
mem | 30 |
restricted | 30 |
hr | 30 |
prostatitis | 30 |
label | 30 |
complication | 30 |
hs | 30 |
sul | 30 |
kits | 30 |
blactx | 30 |
clear | 30 |
emerged | 30 |
displayed | 30 |
genetically | 30 |
hands | 30 |
french | 30 |
routinely | 30 |
cocci | 30 |
mc | 30 |
kidney | 30 |
cis | 30 |
clavulanate | 30 |
institute | 30 |
middle | 30 |
nevertheless | 30 |
observation | 30 |
visa | 29 |
expanded | 29 |
retrospectively | 29 |
prescriptions | 29 |
practices | 29 |
facilities | 29 |
personnel | 29 |
experienced | 29 |
typical | 29 |
pancreatic | 29 |
continued | 29 |
undergoing | 29 |
disseminated | 29 |
pairs | 29 |
sccmec | 29 |
minor | 29 |
just | 29 |
www | 29 |
society | 29 |
spa | 29 |
consultations | 29 |
explained | 29 |
neurological | 29 |
external | 29 |
predict | 29 |
fully | 29 |
alpha | 29 |
fragments | 29 |
twelve | 29 |
hsv | 29 |
protective | 29 |
hcv | 29 |
catarrhalis | 29 |
correctly | 29 |
immediately | 29 |
foreign | 29 |
chromosomal | 29 |
manual | 29 |
partial | 29 |
pyrosequencing | 29 |
involvement | 29 |
multiresistant | 29 |
iran | 29 |
vgs | 29 |
induction | 29 |
enterobacter | 29 |
microbiologic | 29 |
pbp | 29 |
jejuni | 29 |
throughput | 29 |
twice | 29 |
viridans | 28 |
integrons | 28 |
sufficient | 28 |
evaluable | 28 |
variations | 28 |
males | 28 |
cfx | 28 |
service | 28 |
make | 28 |
require | 28 |
seroprevalence | 28 |
right | 28 |
alterations | 28 |
slime | 28 |
fish | 28 |
specifically | 28 |
adherence | 28 |
pool | 28 |
colonised | 28 |
weekly | 28 |
transport | 28 |
genomes | 28 |
nps | 28 |
burn | 28 |
rdna | 28 |
access | 28 |
sets | 28 |
biomerieux | 28 |
eastern | 28 |
mouse | 28 |
tolerated | 28 |
minimal | 28 |
pharmacodynamic | 28 |
commercially | 28 |
amp | 28 |
biofilms | 28 |
dutch | 28 |
intracellular | 28 |
tick | 28 |
norfloxacin | 28 |
dl | 28 |
voriconazole | 28 |
array | 28 |
asia | 27 |
shigella | 27 |
catheters | 27 |
issue | 27 |
analyzed | 27 |
cholerae | 27 |
decision | 27 |
category | 27 |
membrane | 27 |
comorbidities | 27 |
ri | 27 |
take | 27 |
osteomyelitis | 27 |
cro | 27 |
subjected | 27 |
odds | 27 |
organs | 27 |
fluids | 27 |
superior | 27 |
correct | 27 |
unusual | 27 |
similarly | 27 |
tcda | 27 |
locus | 27 |
persistent | 27 |
org | 27 |
ent | 27 |
bid | 27 |
breakpoint | 27 |
similarity | 27 |
leads | 27 |
pos | 27 |
synergy | 27 |
location | 27 |
rest | 27 |
kp | 27 |
underwent | 27 |
suffering | 27 |
solid | 27 |
million | 27 |
slightly | 27 |
binary | 27 |
circulating | 27 |
aspects | 27 |
rods | 27 |
epidemics | 27 |
parallel | 27 |
sulfamethoxazole | 27 |
dalbavancin | 27 |
lvx | 27 |
child | 27 |
radiological | 27 |
ongoing | 27 |
rad | 27 |
give | 27 |
light | 27 |
chi | 27 |
repeat | 27 |
implemented | 27 |
ebv | 26 |
efforts | 26 |
admissions | 26 |
amount | 26 |
simultaneously | 26 |
mox | 26 |
easily | 26 |
aac | 26 |
nurses | 26 |
cassette | 26 |
comparators | 26 |
rarely | 26 |
hence | 26 |
doctors | 26 |
sampled | 26 |
person | 26 |
marker | 26 |
geographic | 26 |
rat | 26 |
articles | 26 |
representative | 26 |
garenoxacin | 26 |
brucellosis | 26 |
assigned | 26 |
recognition | 26 |
ir | 26 |
placebo | 26 |
parvovirus | 26 |
representing | 26 |
neither | 26 |
deaths | 26 |
removed | 26 |
detailed | 26 |
inoculation | 26 |
devices | 26 |
manuscript | 26 |
west | 26 |
capacity | 26 |
er | 26 |
targeting | 26 |
agreement | 26 |
chosen | 26 |
colony | 26 |
programme | 26 |
depending | 26 |
focused | 26 |
power | 26 |
saline | 26 |
pigs | 26 |
pancreas | 26 |
screen | 26 |
relationships | 26 |
sterile | 26 |
institution | 26 |
consider | 26 |
traditional | 26 |
reviews | 26 |
vzv | 26 |
fourth | 26 |
threat | 26 |
marrow | 26 |
classification | 26 |
students | 26 |
northern | 26 |
attention | 26 |
obtain | 26 |
august | 26 |
untreated | 25 |
encountered | 25 |
tcid | 25 |
seventy | 25 |
event | 25 |
enhanced | 25 |
disc | 25 |
square | 25 |
listeria | 25 |
diverse | 25 |
cloacae | 25 |
athens | 25 |
white | 25 |
supplemented | 25 |
purposes | 25 |
tetracyclines | 25 |
subgroup | 25 |
coronaviruses | 25 |
project | 25 |
inappropriate | 25 |
referred | 25 |
smai | 25 |
seasons | 25 |
fast | 25 |
empirical | 25 |
tcdb | 25 |
fangcang | 25 |
likelihood | 25 |
altered | 25 |
toxigenic | 25 |
independently | 25 |
chloroquine | 25 |
labelled | 25 |
fingers | 25 |
multivariable | 25 |
pn | 25 |
changed | 25 |
discrimination | 25 |
genus | 25 |
detectable | 25 |
largely | 25 |
uncommon | 25 |
concerning | 25 |
amphotericin | 25 |
forms | 25 |
hrv | 25 |
policy | 25 |
glucose | 25 |
solution | 25 |
summary | 25 |
intervals | 25 |
ventilator | 25 |
though | 25 |
technical | 25 |
vomiting | 25 |
parts | 25 |
ventilation | 25 |
susceptibilities | 24 |
finland | 24 |
services | 24 |
pancreatitis | 24 |
episode | 24 |
yield | 24 |
identifying | 24 |
address | 24 |
cellulitis | 24 |
basic | 24 |
los | 24 |
microorganism | 24 |
transplantation | 24 |
coding | 24 |
face | 24 |
rooms | 24 |
start | 24 |
separate | 24 |
differentiation | 24 |
medications | 24 |
oropharyngeal | 24 |
iu | 24 |
pp | 24 |
exception | 24 |
simulations | 24 |
aortic | 24 |
adjustment | 24 |
va | 24 |
completely | 24 |
follows | 24 |
questions | 24 |
targets | 24 |
preceding | 24 |
consensus | 24 |
initiation | 24 |
explain | 24 |
pcv | 24 |
processed | 24 |
spanish | 24 |
shiga | 24 |
guide | 24 |
delivery | 24 |
man | 24 |
nursing | 24 |
associations | 24 |
nct | 24 |
original | 24 |
extensive | 24 |
epithelial | 24 |
shelter | 24 |
microbiota | 24 |
cephalosporin | 24 |
view | 24 |
compound | 24 |
serotyping | 24 |
availability | 24 |
pertussis | 24 |
mucosa | 24 |
cervical | 24 |
left | 24 |
zone | 24 |
november | 24 |
univariate | 24 |
example | 24 |
tehran | 24 |
resource | 23 |
homes | 23 |
dairy | 23 |
random | 23 |
dominant | 23 |
reasons | 23 |
employed | 23 |
determinant | 23 |
confirmation | 23 |
cpm | 23 |
se | 23 |
inter | 23 |
matrix | 23 |
seropositive | 23 |
reached | 23 |
tools | 23 |
online | 23 |
peptide | 23 |
inpatients | 23 |
cattle | 23 |
interaction | 23 |
nausea | 23 |
gold | 23 |
dexamethasone | 23 |
avian | 23 |
definitions | 23 |
forty | 23 |
cpe | 23 |
influenced | 23 |
replication | 23 |
ranges | 23 |
operation | 23 |
damage | 23 |
mellitus | 23 |
anthracis | 23 |
hplc | 23 |
cardiovascular | 23 |
icus | 23 |
vanc | 23 |
exhibit | 23 |
carry | 23 |
asp | 23 |
resolution | 23 |
winter | 23 |
beds | 23 |
ha | 23 |
imaging | 23 |
delay | 23 |
biopsies | 23 |
orf | 23 |
usual | 23 |
characterize | 23 |
abstracts | 23 |
removal | 23 |
estimates | 23 |
city | 23 |
toxic | 23 |
rank | 23 |
persistence | 23 |
peripheral | 23 |
monitor | 23 |
device | 23 |
faeces | 23 |
drainage | 23 |
rd | 23 |
milk | 23 |
meat | 23 |
copd | 23 |
epidemiologic | 23 |
aids | 23 |
circulation | 23 |
promising | 23 |
undertaken | 23 |
lps | 23 |
band | 23 |
neonatal | 23 |
oncology | 23 |
outside | 23 |
arthritis | 23 |
comprised | 23 |
fresh | 23 |
disorders | 23 |
blakpc | 23 |
fungi | 23 |
expert | 22 |
seasonality | 22 |
tc | 22 |
observations | 22 |
contributed | 22 |
monitored | 22 |
july | 22 |
german | 22 |
involving | 22 |
fluorescence | 22 |
polymicrobial | 22 |
consequences | 22 |
venous | 22 |
mitis | 22 |
differential | 22 |
nocardia | 22 |
understand | 22 |
completed | 22 |
avoid | 22 |
simultaneous | 22 |
differed | 22 |
indeed | 22 |
mobile | 22 |
consequently | 22 |
injury | 22 |
hc | 22 |
preparation | 22 |
electronic | 22 |
stress | 22 |
grampositive | 22 |
supports | 22 |
zoonotic | 22 |
caspofungin | 22 |
stigma | 22 |
pet | 22 |
wall | 22 |
consistently | 22 |
hd | 22 |
characteristic | 22 |
vaccines | 22 |
bacteriuria | 22 |
pv | 22 |
secretions | 22 |
classical | 22 |
aor | 22 |
seem | 22 |
integrated | 22 |
self | 22 |
droplets | 22 |
nm | 22 |
newer | 22 |
promoter | 22 |
enteric | 22 |
cefoxitin | 22 |
polymorphism | 22 |
select | 22 |
pathogenicity | 22 |
exceeded | 22 |
subgroups | 22 |
september | 22 |
parenteral | 22 |
unrelated | 22 |
fluorescent | 22 |
inducible | 22 |
blind | 22 |
females | 22 |
fifty | 22 |
introduced | 22 |
attack | 22 |
monoclonal | 21 |
stability | 21 |
shedding | 21 |
glycylcycline | 21 |
consultation | 21 |
regional | 21 |
nested | 21 |
composition | 21 |
thank | 21 |
performing | 21 |
srf | 21 |
define | 21 |
base | 21 |
linear | 21 |
reason | 21 |
acids | 21 |
rp | 21 |
borrelia | 21 |
beyond | 21 |
district | 21 |
discharged | 21 |
stable | 21 |
team | 21 |
geographical | 21 |
complement | 21 |
visual | 21 |
requires | 21 |
definite | 21 |
decreasing | 21 |
septic | 21 |
nervous | 21 |
imp | 21 |
pallidum | 21 |
markers | 21 |
pg | 21 |
receptor | 21 |
polymorphisms | 21 |
fqs | 21 |
pilot | 21 |
foot | 21 |
providing | 21 |
eligible | 21 |
scientific | 21 |
relatedness | 21 |
member | 21 |
indirect | 21 |
poultry | 21 |
fusb | 21 |
ib | 21 |
parameter | 21 |
blot | 21 |
widespread | 21 |
otitis | 21 |
extremely | 21 |
position | 21 |
contain | 21 |
machine | 21 |
xf | 21 |
herpes | 21 |
kinetics | 21 |
rats | 21 |
prosthetic | 21 |
neutrophils | 21 |
maintained | 21 |
mitt | 21 |
terminal | 21 |
establish | 21 |
lost | 21 |
organization | 21 |
exact | 21 |
england | 20 |
alcohol | 20 |
true | 20 |
ribotyping | 20 |
publication | 20 |
expressing | 20 |
visit | 20 |
visits | 20 |
max | 20 |
mpcr | 20 |
focusing | 20 |
never | 20 |
transmitted | 20 |
prodesse | 20 |
oxygen | 20 |
communication | 20 |
bacteriological | 20 |
island | 20 |
lamp | 20 |
haematology | 20 |
directed | 20 |
amplicons | 20 |
identity | 20 |
know | 20 |
cutaneous | 20 |
exist | 20 |
spn | 20 |
yersinia | 20 |
bacterium | 20 |
challenges | 20 |
oligonucleotide | 20 |
spreading | 20 |
integron | 20 |
safe | 20 |
histological | 20 |
details | 20 |
sweden | 20 |
tm | 20 |
dyspeptic | 20 |
asthma | 20 |
discussed | 20 |
bl | 20 |
ear | 20 |
whose | 20 |
stain | 20 |
comprising | 20 |
creatinine | 20 |
africa | 20 |
cleaning | 20 |
mrs | 20 |
hypertension | 20 |
interactions | 20 |
alleles | 20 |
paper | 20 |
mpc | 20 |
reflect | 20 |
streptomycin | 20 |
proper | 20 |
returning | 20 |
written | 20 |
orally | 20 |
enterotoxin | 20 |
equivalent | 20 |
lymphocyte | 20 |
rama | 20 |
norovirus | 20 |
grown | 20 |
gnb | 20 |
haemolyticus | 20 |
penicillins | 20 |
toc | 20 |
india | 20 |
onto | 20 |
dry | 20 |
juice | 19 |
article | 19 |
limits | 19 |
physician | 19 |
enhance | 19 |
neonates | 19 |
pharyngeal | 19 |
lacking | 19 |
head | 19 |
temporal | 19 |
personal | 19 |
covered | 19 |
phoenix | 19 |
act | 19 |
melting | 19 |
amb | 19 |
platforms | 19 |
retrieved | 19 |
positions | 19 |
continue | 19 |
acnes | 19 |
dilutions | 19 |
bronchitis | 19 |
mumps | 19 |
components | 19 |
pyogenic | 19 |
larger | 19 |
etc | 19 |
actual | 19 |
ticks | 19 |
favourable | 19 |
unclear | 19 |
nose | 19 |
occupational | 19 |
apparent | 19 |
awareness | 19 |
recognised | 19 |
dialysis | 19 |
garinii | 19 |
mastitis | 19 |
back | 19 |
discovered | 19 |
epi | 19 |
american | 19 |
london | 19 |
canada | 19 |
learning | 19 |
pa | 19 |
sdd | 19 |
lesion | 19 |
mechanical | 19 |
tocilizumab | 19 |
former | 19 |
declare | 19 |
rn | 19 |
latin | 19 |
aom | 19 |
rabbits | 19 |
amc | 19 |
biology | 19 |
spike | 19 |
core | 19 |
evolutionary | 19 |
aims | 19 |
tablets | 19 |
cotrimoxazole | 19 |
headache | 19 |
bla | 19 |
acne | 19 |
ceftobiprole | 19 |
constant | 19 |
deep | 19 |
fda | 19 |
nalidixic | 19 |
tetr | 19 |
vaccinated | 19 |
aph | 19 |
interquartile | 18 |
attributable | 18 |
cdc | 18 |
spontaneous | 18 |
turkish | 18 |
hbv | 18 |
purified | 18 |
roc | 18 |
pap | 18 |
offer | 18 |
professionals | 18 |
characterise | 18 |
designated | 18 |
panton | 18 |
committee | 18 |
perspective | 18 |
immunisation | 18 |
harbour | 18 |
insights | 18 |
virology | 18 |
ag | 18 |
steroids | 18 |
monthly | 18 |
outer | 18 |
modelling | 18 |
cohorts | 18 |
dt | 18 |
algorithms | 18 |
measure | 18 |
spleen | 18 |
recruited | 18 |
titres | 18 |
prediction | 18 |
clustered | 18 |
verigene | 18 |
dogs | 18 |
databases | 18 |
ssti | 18 |
hybridization | 18 |
horizontal | 18 |
mdrsp | 18 |
cefpodoxime | 18 |
solutions | 18 |
predicted | 18 |
vascular | 18 |
varies | 18 |
krusei | 18 |
ser | 18 |
decisions | 18 |
diluted | 18 |
pbmc | 18 |
concurrent | 18 |